Find

Department of Clinical Medicine

HemeLab

Publications

Sort by: Date | Author | Title

Petruskevicius, I., Ludvigsen, M., Kamper, P., Hjortebjerg, R., Sørensen, B. S., Nielsen, B., Honoré, B. & d'Amore, F. A. (2014). Galectin-1 as a novel biomarker in haematologic malignancies treated with non-myeloablative haematopoietic stem cell transplantation.

Petruskevicius, I., Ludvigsen, M., Kamper, P. M. H., Hjortebjerg, R., Sørensen, B. S., Nielsen, B., Honoré, B. & D'Amore, F. A. (2014). Galectin-1 as a novel prognostic biomarker in haematologic malignancies treated with non-myeloablative haemopoietic stem cell transplantation.. Poster session presented at European Group for Blood and Marrow Transplantation Annual Meeting, Milano, Italy.

Ludvigsen, M. (2014). Protein profiling of lymphomas. Identification and characterization of disease markers and drug targets: PhD dissertation.

Ludvigsen, M., Pedersen, M. B., Poulsen, T. S., Hamilton-Dutoit, S. J., Besenbacher, S., Bendix, K., Møller, M. B., D'Amore, F. A. & Honoré, B. (2014). Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified: Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified. Blood, 124(21), Article 124.

Vorup-Jensen, T., Rosenberg, C. & Petersen, E. (2014). Reply to Shin and Bayry on "An age-related decline of CD62L and vaccine response: a role of microRNA 92a?". Human Vaccines & Immunotherapeutics, 10(5).

Rosenberg, C., Bovin, N. V., Bram, L. V., Flyvbjerg, E., Erlandsen, M., Vorup-Jensen, T. & Petersen, E. (2013). Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen. Human Vaccines & Immunotherapeutics, 9(7), 1466-76. https://doi.org/10.4161/hv.24480

Snipsøyr, M. G., Wiggers, H., Knudsen, J. B., Ludvigsen, M., Poulsen, S. H., Petersen, E. & Honoré, B. (2013). Identification of putative, novel biomarkers for infective endocarditis by proteomic analysis. Poster session presented at 30th annual meeting of Nordic Society of Clinical Microbiology and Infectious Diseases, Aarhus, Denmark.

Ludvigsen, M. (2013). Identifikation af sygdomsmarkører via en proteom-baseret strategi for lymfekræft. BestPractice Hæmatologi, Nr 7(p 15-16).

Rosenberg, C. A. (2013). Investigation of the immune responses induced after immunization against the intracellular microorganisms Toxoplasma gondii and Hepatitis B virus. Fællestrykkeriet for Sundhedsvidenskab, Aarhus Universitet.

Ludvigsen, M., Madsen, C., Kamper, P., Hamilton-Dutoit, S. J., Bendix, K., D'Amore, F. A. & Honoré, B. (2013). Proteomic analysis identifies differential expression patterns in follicular lymphoma patients with or without subsequent histological transformation. Hematological Oncology, 31, 203.

Ludvigsen, M., Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Moeller, M. B., Noergaard, P., D'Amore, F. A. & Honoré, B. (2013). Proteomic analysis identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified. Hematological Oncology, 31, 174-175.

Thorlacius-Ussing, L., Ludvigsen, M., Kirkeby, S., Vorum, H. & Honoré, B. (2013). Proteomic analysis of tissue from α1,3-galactosyltransferase knockout mice reveals that a wide variety of proteins and protein fragments change expression level. PLoS One.

Ludvigsen, M., Kamper, P., Sørensen, B. S., Hamilton Dutoit, S. J., Bendix, K., Møller, M. B., Alsner, J., D'Amore, F. A. & Honoré, B. (2013). Specific degradation pattern of peroxiredoxin-1 correlates with adverse outcome in classical Hodgkin lymphoma patients..

Ludvigsen, M., Kamper, P., Hamilton-Dutoit, S. J., Bendix, K., D'Amore, F. A. & Honoré, B. (2011). Different protein expression patterns may indicate different disease mechanisms in older and younger cHL patients. Annals of Oncology, 22(suppl4), 393.

Kamper, P., Ludvigsen, M., Bendix, K., Hamilton-Dutoit, S. J., Rabinovich, G. A., Møller, M. B., Nyengaard, J. R., Honoré, B. & d'Amore, F. (2011). Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma. Blood, 117(24), 6638-49. https://doi.org/10.1182/blood-2010-12-327346

Ludvigsen, M., Kamper, P., Bendix, K., Hamilton Dutoit, S. J., Rabinovich, G. A., Møller, M. B., Nyengaard, J. R., D'Amore, F. A. & Honoré, B. (2011). Translational research identifies prognostic markers including galectin-1 in the tumor microenvironment of cHL predictive for relapsed /refractory disease.

Rosenberg, C. A., Vorup-Jensen, T. & Petersen, E. (2010). Age-specific seropositivity towards hepatitis B vaccination and response to booster immunization. Poster session presented at PhD Day 2010, Aarhus.

Kamper, P., Ludvigsen, M., Bendix, K., Hamilton-Dutoit, S. J., Rabinovich, G. A., Møller, M. B., Nyengaard, J. R., Honoré, B. & D'Amore, F. A. (2010). Identification of galectin-1 as prognostic biomarker in younger patients with advanced stage classical Hodgkin Lymphoma. Haematologica.

Ludvigsen, M., Kamper, P., Bendix, K., Hamilton-Dutoit, S. J., Møller, M. B., Rabinovich, G. A., D'Amore, F. A. & Honoré, B. (2010). Outcome-related protein expression profile in patients with classical Hodgkin Lymphoma. Haematologica.

Rosenberg, C. A., Petersen, E. & Vorup-Jensen, T. (2009). Age-specific seropositivity towards hepatitis B vaccination and response to booster immunization. Poster session presented at Elsinore Series on Infection Immunity , Helsingør, Denmark.

Displaying results 101 to 120 out of 128

6

Revised 11.09.2025

-

Maja Ludvigsen